Title  | Date  | Price  |
|---|
Pharmacies and Drug Retailers in China IBISWorld Industry Report
| Sep 2009 |
£375 |
Leading Pharmaceutical Companies Marketing Tactics
| Sep 2009 |
£900 |
New Multi-Marketing Channel Strategies Healthcare
| Aug 2009 |
£2,315 |
Launching next Generation Oncology Products Evolving Strategies in a Payor??s Market
| Aug 2009 |
£2,305 |
Pharmaceutical Sales Force Effectiveness Strategies Evaluating Evolving Sales Models & Advanced Technology for a Customer Centric Approach
| Aug 2009 |
£2,305 |
The Eastern European Pharmaceutical Market Outlook To 2014 Policy environment, market structure, competitive landscape, growth opportunities
| Jun 2009 |
£2,305 |
Reinventing Pharmaceutical Sales Forces
| May 2009 |
£4,760 |
Research Report of the Third Terminal Market of Chinese Medinces, 2009
| May 2009 |
£990 |
Optimizing Key Opintion Leader Relationships Best Practices in Kol Management
| Apr 2009 |
£3,125 |
Pipeline and Commercial Insight: Nicotine Dependence - Chantix issues overshadow vaccine potential Healthcare
| Mar 2009 |
£8,070 |
Forecast Insight: Opioids - Saturation limits the commercial potential of individual brands Healthcare
| Mar 2009 |
£7,955 |
Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos Healthcare
| Mar 2009 |
£2,315 |
Using Public Relations to Launch, Grow and Extend Your Brands
| Mar 2009 |
£4,090 |
Stakeholder Opinions: Back Pain - Gain competitive edge by targeting subpopulations Healthcare
| Mar 2009 |
£2,315 |
Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life Healthcare
| Mar 2009 |
£2,315 |
Key Opinion Leaders: Relationship Management and Segmentation Data
| Feb 2009 |
£4,760 |
European CME Forum: First Annual Meeting
| Feb 2009 |
£75 |
Medical Science Liaisons Gaining Access and Forging Relationships with Key Opinion Leaders
| Feb 2009 |
£1,685 |
Antithrombotics Market Forecast
| Jan 2009 |
£7,955 |
Understanding Pharmacogenomics Maximum Efficacy with Minimal Adverse Effects
| Jan 2009 |
£305 |
Hepatitis C Market Forecast
| Jan 2009 |
£7,955 |
Driving Successful Pharma Brands: Case Studies of Real Product Launches
| Jan 2009 |
£4,760 |
CV & Diabetes Market Forecast
| Jan 2009 |
£7,955 |
Performance Benchmark Optimizing Marketing Staff Levels to Drive Growth
| Dec 2008 |
£2,105 |
Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight
| Dec 2008 |
£2,400 |
Outcomes-Based Pharmaceutical Pricing
| Dec 2008 |
£4,760 |
Forecast Insight: Antithrombotics - Market growth dependent on new agents
| Dec 2008 |
£7,955 |
Pharmaceutical Alliance Management
| Dec 2008 |
£3,710 |
Forecast Insight: Epilepsy - Future market upgrade following new drug launches
| Dec 2008 |
£7,955 |
Improve Market Research Impact
| Dec 2008 |
£4,760 |
Competitive Intelligence Policies, Ethics and Data Collection Navigating The Gray Zone
| Nov 2008 |
£3,215 |
Pharmaceutical Product Launch Evaluation Excellence Processes & Measures to Evaluate Launch Success
| Nov 2008 |
£2,705 |
Pre-Launch Planning Priming Your Pharmaceutical Brand for Profit and Success
| Nov 2008 |
£997 |
Public Relations Excellence Using Pr to Launch, Grow, and Extend Your Brands
| Oct 2008 |
£4,810 |
Product Commercialization Excellence Preparation and Management of Fixed-Dose Combination Drug Products
| Oct 2008 |
£3,065 |
Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability
| Aug 2008 |
£5,410 |
Pharmaceutical New Product Planning Structure and Activities to Drive Growth and Profitability
| Aug 2008 |
£5,410 |
The High Performing Pharmaceutical District Sales Manager Current Trends & Future Directions
| Jul 2008 |
£4,745 |
Pharmaceutical New Product Commercialization Preparing The Market for Success
| Jul 2008 |
£2,760 |
Pharmaceutical New Product Commercialization Preparing The Market for Success
| Jul 2008 |
£2,760 |
Pharmaceutical Markets in Brazil, Russia, India and China (Bric Nations)
| Jul 2008 |
£2,105 |
Pharmaceutical Competitive Intelligence Excellence Optimizing Data Collection within Approved Guidelines
| Apr 2008 |
£2,400 |
U.S. Sales Communications Excellence Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications
| Apr 2008 |
£1,500 |
Rewarding & Recognizing Top-Performing Sales People
| Mar 2008 |
£3,605 |
Bigpharma Partnering Agreements
| Mar 2008 |
£1,195 |
Pharmaceutical Distribution in Europe The Emergence of Direct-to-Pharmacy Supply
| Feb 2008 |
£995 |
A Guidebook to Pharma Brand Optimization Lifecycle Management Strategy
| Jan 2008 |
£3,090 |
Pharma Sales World 2007 Advanced Sales Force Remodelling Strategies in a Multi-Channel Environment
| Jan 2008 |
£75 |
Best Practices in Designing Effective Brand Teams Brand Governance and Brand Team Management
| Dec 2007 |
£2,100 |
Pharmaceutical Product Approval Trends, 2007 Key Market Benchmarks And Strategic Insights
| Dec 2007 |
£1,299 |
Pharmaceutical Sales Force Effectiveness Metrics Are You Measuring the Wrong Things?
| Nov 2007 |
£495 |
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family Sales & Marketing
| Oct 2007 |
£4,570 |
Global Pharmaceutical Marketing A Practical Guide to Codes and Compliance
| Oct 2007 |
£80 |
Pharmaceutical Medical Publications Market Preparation & Strategic Support
| Sep 2007 |
£2,040 |
Launch Strategies - Analyzing Market Trends and Regulatory Impacts
| Aug 2007 |
£9,140 |
Bringing Drugs to Market The role of CRM in improving sales & marketing (Review Report)
| Aug 2007 |
£1,140 |
Delivering Maximum Brand Impact via Pharmaceutical Market Analytics
| Jul 2007 |
£2,095 |
Online Marketing and eDetailing Europe
| Jul 2007 |
£75 |
Drug Repositioning Strategies Innovative Strategies To Boost Pipeline Productivity
| Jun 2007 |
£1,150 |
Stakeholder Opinions: Fibromyalgia - Potentially lucrative market soon to become reality
| May 2007 |
£2,280 |
Pharmaceutical Product Relaunch Preserving Market Share through Line Extension and New Market Entry Strategies
| Apr 2007 |
£4,760 |
Pharmaceutical Customer Relationship Management Developing and Improving CRM
| Apr 2007 |
£4,760 |
Early-Stage Pharmaceutical Marketing Budgets Preparing for Product Launch
| Mar 2007 |
£2,720 |
China Medical Sales Channel Report, 2006-2007
| Mar 2007 |
£540 |
Pharma Marketing ROI
| Jan 2007 |
£75 |
Post-Launch Brand Marketing in Select Affiliate Markets
| Jan 2007 |
£2,040 |
Optimizing Sales Force Effectiveness From quantity to quality
| Nov 2006 |
£4,570 |
Pharmaceutical Sales Training Groups Building Better Sales Forces
| Oct 2006 |
£2,040 |
A Product Director's Guide to Promotional Mix
| Sep 2006 |
£2,040 |
Patient Compliance Europe
| Aug 2006 |
£75 |
Sales Force Effectiveness Benchmarking The Resources and Structure Required to Service The U.S. Hospital Marketplace
| Jun 2006 |
£2,975 |
Sales Force Effectiveness Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace
| Jun 2006 |
£2,075 |
Pharmaceutical Sales Training: Turning New Hires into Top Performers
| Jun 2006 |
£2,920 |
Marketing Mid-Tier Pharmaceutical Brands Winning Resources for near-Blockbusters
| May 2006 |
£2,040 |
Blockbuster Pharmaceutical Launches Establishing Market Leadership
| May 2006 |
£2,040 |
Small & Specialty Drug Branding Tapping Niche Market Potential
| May 2006 |
£2,040 |
Drug Safety for Marketed Drugs
| Apr 2006 |
£75 |
Marketing ROI for Pharma
| Jan 2006 |
£75 |
Pharmacogenomics: New Technologies In the Development of Personalized Therapies
| Sep 2005 |
£2,730 |
Global Pharmaceutical Launches Marketing Budgets and Staffing (Phase 3 to Post-Launch)
| Jan 2005 |
£2,040 |
Managing Sales Training to Accelerate Speed to Productivity
| Dec 2004 |
£1,500 |
Product Relaunch Excellence Transforming Lackluster Pharmaceutical Products into Market Success Stories
| Oct 2004 |
£2,795 |
Best Practices in Global Pharmaceutical Launches
| Oct 2004 |
£4,210 |
Medical Affairs Excellence Structuring, Funding, & Aligning for Global Success
| May 2004 |
£2,840 |
Launching Pharmaceutical Megabrands Best Practices in Marketing Blockbusters
| Feb 2004 |
£4,785 |